A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs
- PMID: 23935102
- PMCID: PMC3784704
- DOI: 10.1074/jbc.M113.499244
A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs
Abstract
Small RNAs undergo maturation events that precisely determine the length and structure required for their function. CRISPRs (clustered regularly interspaced short palindromic repeats) encode small RNAs (crRNAs) that together with CRISPR-associated (cas) genes constitute a sequence-specific prokaryotic immune system for anti-viral and anti-plasmid defense. crRNAs are subject to multiple processing events during their biogenesis, and little is known about the mechanism of the final maturation step. We show that in the Staphylococcus epidermidis type III CRISPR-Cas system, mature crRNAs are measured in a Cas10·Csm ribonucleoprotein complex to yield discrete lengths that differ by 6-nucleotide increments. We looked for mutants that impact this crRNA size pattern and found that an alanine substitution of a conserved aspartate residue of Csm3 eliminates the 6-nucleotide increments in the length of crRNAs. In vitro, recombinant Csm3 binds RNA molecules at multiple sites, producing gel-shift patterns that suggest that each protein binds 6 nucleotides of substrate. In vivo, changes in the levels of Csm3 modulate the crRNA size distribution without disrupting the 6-nucleotide periodicity. Our data support a model in which multiple Csm3 molecules within the Cas10·Csm complex bind the crRNA with a 6-nucleotide periodicity to function as a ruler that measures the extent of crRNA maturation.
Keywords: Adaptive Immunity; Antibiotic Resistance; Bacterial Conjugation; Bacterial Genetics; CRISPR; Microbiology; Small RNA; Staphylococcus.
Figures
Similar articles
-
Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases.Nucleic Acids Res. 2017 Feb 28;45(4):2112-2123. doi: 10.1093/nar/gkw891. Nucleic Acids Res. 2017. PMID: 28204542 Free PMC article.
-
Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system.J Bacteriol. 2014 Jan;196(2):310-7. doi: 10.1128/JB.01130-13. Epub 2013 Nov 1. J Bacteriol. 2014. PMID: 24187086 Free PMC article.
-
Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.J Mol Biol. 2019 Feb 15;431(4):748-763. doi: 10.1016/j.jmb.2019.01.009. Epub 2019 Jan 11. J Mol Biol. 2019. PMID: 30639408
-
Approaches to study CRISPR RNA biogenesis and the key players involved.Methods. 2020 Feb 1;172:12-26. doi: 10.1016/j.ymeth.2019.07.015. Epub 2019 Jul 17. Methods. 2020. PMID: 31325492 Review.
-
Function and regulation of clustered regularly interspaced short palindromic repeats (CRISPR) / CRISPR associated (Cas) systems.Viruses. 2012 Oct 19;4(10):2291-311. doi: 10.3390/v4102291. Viruses. 2012. PMID: 23202464 Free PMC article. Review.
Cited by
-
Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.RNA. 2015 Jun;21(6):1147-58. doi: 10.1261/rna.049130.114. Epub 2015 Apr 22. RNA. 2015. PMID: 25904135 Free PMC article.
-
Modulating the Cascade architecture of a minimal Type I-F CRISPR-Cas system.Nucleic Acids Res. 2016 Jul 8;44(12):5872-82. doi: 10.1093/nar/gkw469. Epub 2016 May 23. Nucleic Acids Res. 2016. PMID: 27216815 Free PMC article.
-
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity.Elife. 2019 Apr 3;8:e45393. doi: 10.7554/eLife.45393. Elife. 2019. PMID: 30942690 Free PMC article.
-
A coiled-coil domain acts as a molecular ruler to regulate O-antigen chain length in lipopolysaccharide.Nat Struct Mol Biol. 2015 Jan;22(1):50-56. doi: 10.1038/nsmb.2935. Epub 2014 Dec 15. Nat Struct Mol Biol. 2015. PMID: 25504321 Free PMC article.
-
The structure of a Type III-A CRISPR-Cas effector complex reveals conserved and idiosyncratic contacts to target RNA and crRNA among Type III-A systems.PLoS One. 2023 Jun 23;18(6):e0287461. doi: 10.1371/journal.pone.0287461. eCollection 2023. PLoS One. 2023. PMID: 37352230 Free PMC article.
References
-
- Barrangou R., Fremaux C., Deveau H., Richards M., Boyaval P., Moineau S., Romero D. A., Horvath P. (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315, 1709–1712 - PubMed
-
- Garneau J. E., Dupuis M. È., Villion M., Romero D. A., Barrangou R., Boyaval P., Fremaux C., Horvath P., Magadán A. H., Moineau S. (2010) The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468, 67–71 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
